Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Benralizumab
(Fasenra (TN))		[1] Benralizumab (Fasenra)[1] Benralizumab (Fasenra (TN)) 💬 [1] IL5RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[5] 44, 45, 98, 162, 299 💬
2Biological: Benralizumab, Biological: Placebo to Mepolizumab
(Fasenra (TN))		[2] Benralizumab (Fasenra),
Mepolizumab		[2] Mepolizumab ,
Benralizumab (Fasenra (TN)) 💬 		[2] IL5,
IL5RA 💬 		[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[1] 44 💬
3Biological: Mepolizumab, Biological: Placebo to Benralizumab
(Fasenra (TN))		[2] Benralizumab (Fasenra),
Mepolizumab		[2] Mepolizumab ,
Benralizumab (Fasenra (TN)) 💬 		[2] IL5,
IL5RA 💬 		[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[1] 44 💬
4Fasenra[1] Benralizumab (Fasenra)[1] Benralizumab (Fasenra (TN)) 💬 [1] IL5RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[5] 44, 45, 98, 162, 299 💬